Prior to joining Nicklaus Children's Hospital, formerly Nicklaus Children’s Hospital, Dr. Rhodes served as chief for the Duke Clinical Heart Program and Duke Children’s Heart Center in Durham, North Carolina. He was also co-director of the Duke Adult Congenital Heart Program.
Dr. Rhodes received his medical degree from The Brody School of Medicine in Greenville, North Carolina and completed his fellowship in cardiology at The Mount Sinai Medical Center in New York, where his mentors included several members of the current Heart Program team. He pursued additional training in interventional catheterization for children and adults at The Cleveland Clinic Foundation in Cleveland.
Dr. Rhodes’clinical interests involve diagnostic and interventional catheterization procedures for children and adults with complex congenital heart disease. He has helped pioneer several techniques, including transcatheter atrial septal closure with the Gore Helex Septal Occluder, intracardiac echocardiographic imaging to guide catheter interventions, cutting balloon angioplasty of stenotic branch pulmonary arteries, and pulmonary vein stent angioplasty for pulmonary vein stenosis following radiofrequency ablation of atrial fibrillation. He is currently the National Principal Investigator for the REDUCE trial for the management of patent foramen ovale in the setting of cryptogenic stroke and is an investigator for trials including the new Gore Septal Occluder device, Edwards Lifesciences pulmonary stent valve, MELODY pulmonary stent valve, and covered stent angioplasty for coarctation of the aorta.